Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • spapillon
    Junior Member
    • Nov 2011
    • 4

    #1

    Problems with RNA-seq analysis results

    Hi everyone,

    This is my first post here, be sure to let me know if I break a rule of conduct or anything. Tricks & Tips are appreciated.

    The situation:
    I'm currently trying to analyze RNA-seq data from Illumina Body Map 2.0. I've built a pipeline that seems reasonable and used it to asses quality, trim, map, analyze RNA-seq data with the standard tools. The pipeline is for 100bp single end reads.

    The pipeline:
    Quality (fastx_tools for trimming and filtering, FastQC for reporting)
    fastq_quality_filter -Q33 -q 20 -p 80 <FASTQC_FILE>
    fastq_quality_trimmer -Q33 -t 20 -l 50 <FILTER_OUT>
    fastqc <TRIM_OUT>

    Assembling
    tophat --solexa-quals <UCSC hg19 REF> <TRIM_OUT>

    Analysis
    cufflinks <TOPHAT_OUT>
    cuffcompare -r <UCSC hg19 ANNOTATION> -R <CUFFLINKS_OUT>

    The problems
    The output of cuffcompare (cuffcmp.tacking) identifies:
    13586 [23.32%] novel (class code j)
    6127 [10.51%] intronic (class code i)
    19145 [32.86%] contained (class code c)

    In this sample, novel+intronic > contained. I'm highly dubious of the trustfulness of those results since one would not expect such high number of non previously reported transcripts. If anyone could point out a flaw in the pipeline or my interpretation of the obtained results I would greatly appreciate it. Do tell if I need to give more details on any part.

    Best regards,

    Simon
    Last edited by spapillon; 11-29-2011, 09:48 PM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...